Antiangiogenic Factors in Gastric Cancer
NCT00735566 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 240
Last updated 2012-10-18
Summary
Endogenous antiangiogenic factors are related with gastric cancer progression.
Conditions
Sponsors & Collaborators
-
National Cancer Center, Korea
lead OTHER_GOV
Principal Investigators
-
Jun Ho Lee, M.D., Ph.D · Gastric Cancer Branch, National Cancer Center
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-04-30
- Primary Completion
- 2008-07-31
- Completion
- 2012-01-31
Countries
- South Korea
Study Locations
More Related Trials
-
A Multifactor Prediction Model for Non-curative Outcomes in Mixed-type Early Gastric Cancer
NCT07096947 ·Status: COMPLETED
-
BReast CAncer Genes(BRCA) Expressions in Metastatic Gastric Cancer
NCT03838406 ·Status: COMPLETED ·Phase: NA
-
Transcriptomic Signatures in Gastric Adenocarcinoma
NCT05319392 ·Status: UNKNOWN
-
Microbiota and Metabolomics of Intestinal Type of Gastric Cancer
NCT06079554 ·Status: RECRUITING
-
Gastric Cancer Registry for Epidemiology and Molecular Risk Factor
NCT03046745 ·Status: UNKNOWN
-
Prognostic and Predictive Impact of Circulating Tumor DNA in Gastric Cancer Treatment
NCT02674373 ·Status: UNKNOWN
-
HER2 Circulating Tumor Cells in Gastric Cancer
NCT01299688 ·Status: COMPLETED
-
Quality Control Study of Laparoscopic Sentinel Node Biopsy in Early Gastric Cancer
NCT01544413 ·Status: COMPLETED ·Phase: NA
-
Pharmacogenomic Study (Adjuvant Chemotherapy)
NCT01470404 ·Status: COMPLETED
-
Evaluating the Safety and Efficacy of SB Injection in Patients With Advanced or Metastatic Gastric Cancer
NCT01305993 ·Status: UNKNOWN ·Phase: PHASE2
-
Application Value of CTCs Detection for Advanced Gastric Cancer Patients
NCT03156777 ·Status: UNKNOWN
-
A Study on the Potential Benefit of Neoadjuvant Therapy for AGC Patients
NCT05442138 ·Status: UNKNOWN
-
Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer((KCSG ST14-05): CATALYSIS
NCT01917552 ·Status: RECRUITING ·Phase: PHASE3
-
Relationship Between Standard Treatment Efficacy and The Tumor Microenvironment in Advanced Gastric Cancer
NCT04850716 ·Status: UNKNOWN
-
Impact of TTC Following Neoadjuvant Chemotherapy on the Prognosis of LAGC
NCT06696963 ·Status: COMPLETED
-
Prospective Assessment of nProfiler® 1 on Prognosis and Chemotherapy Response for Gastric Cancer
NCT04487717 ·Status: ACTIVE_NOT_RECRUITING
-
Investigation of the Proportion of Human Epidermal Growth Factor Receptor 2 Protein Overexpression of Gastric Adenocarcinoma and Prognostic Effect of HER2, and Analysis of Practice Pattern of Herceptin Use in Stage IV Gastric Cancer
NCT02136836 ·Status: UNKNOWN
-
ADCC Against Gastric Cancer Cells
NCT02078362 ·Status: UNKNOWN
-
Gastric Cancer Survival Without Chemotherapy
NCT05125614 ·Status: COMPLETED
-
A Multi-omics-based Metabolic Typing Study of Gastric Cancer
NCT06134011 ·Status: ACTIVE_NOT_RECRUITING
-
The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleeding
NCT02150447 ·Status: TERMINATED ·Phase: PHASE3
-
The Association Between Microplastics and Macrogenomics and Metabolomics in Gastric Cancer
NCT06856382 ·Status: ACTIVE_NOT_RECRUITING
-
Study of S1 Efficacy and Toxicity as Second-line Treatment on Inoperable or Advanced Gastric Cancers
NCT01650766 ·Status: UNKNOWN
-
EGFR-targeted Therapy for Gastric Cancer
NCT04077255 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of the Efficacy of Distal Gastrectomy for the Treatment of Gastric Cancer (a Case Series)
NCT05068635 ·Status: COMPLETED